Faith Ihekweazu, MD, MS
- Gastroenterology, Hepatology and Nutrition
Assistant Professor of Pediatrics, Baylor College of Medicine
Phone:
832-822-3131
Fax:
832-825-4131
Languages: English
Office locations:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Faith Ihekweazu, MD, MS
Dr. Ihekweazu is a dedicated pediatric gastroenterologist, devoted to providing outstanding medical care for her patients. Locally, she is involved with various clinical trials for Inflammatory Bowel Disease therapies at Texas Children’s Hospital.
At the national level, Dr. Ihekweazu is heavily involved with her professional society and is a sought-after speaker and instructor in the field of Pediatric Gastroenterology. Dr. Ihekweazu believes in the importance of clear communication and strives to provide compassionate, patient- and family-centered care for each of her patients.
Clinical Interests
Rett syndrome, inflammatory bowel diseases (ulcerative colitis and Crohn’s disease), healthcare disparities
Research interests
Rett syndrome, inflammatory bowel diseases (ulcerative colitis and Crohn’s disease), healthcare disparities
Education
,
,
,
Organizations
,
,
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Publications
Ihekweazu FD, Grossman AB. Revisiting Methotrexate Therapy for Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr. 2022 Sep 1;75(3):229-230. doi: 10.1097/MPG.0000000000003544. PMID: 35984455
Britto S, Qian J, Ihekweazu F, Kellermayer R. Racial and Ethnic Variation in Presentation, Diagnosis, Treatment and Outcome of Pediatric Crohn's Disease; a Single Center Study. J Pediatr Gastroenterol Nutr. 2022 Sep 1;75(3):313-319. doi: 10.1097/MPG.0000000000003516. PMID: 35687587
Dybbro E, Dongarwar D, Salihu HM, Ihekweazu FD. Trends and Disparities in Pediatric Nonalcoholic Fatty Liver Disease-Associated Hospitalizations in the United States. J Pediatr Gastroenterol Nutr. 2022 Jan 18. doi: 10.1097/MPG.0000000000003384. PMID: 35045557
Ihekweazu FD, Dangarwar D, Salihu H, Kellermayer R. National Trends in Hospitalization, Surgical Resection, and Comorbidities in Pediatric Inflammatory Bowel Disease in the United States, 2002-2015. Int J MCH AIDS. 2021;10(2):231-240. DOI: 10.21106/ijma.522
Ihekweazu FD, Engevik ME, Ruan W, Shi Z, Fultz R, Engevik KA, Chang-Graham AL, Freeborn J, Park ES, Venable S, Horvath TD, Haidacher SJ, Haag AM, Goodwin A, Schady DA, Hyser JM, Spinler JK, Liu Y, Versalovic J. Bacteroides ovatus Promotes IL-22 Production and Reduces Trinitrobenzene Sulfonic Acid-Driven Colonic Inflammation. Am J Pathol. 2021 Apr;191(4):704-719. doi: 10.1016/j.ajpath.2021.01.009. Epub 2021 Jan 28. PMID: 33516788
Ihekweazu FD, Fofanova T, Palacios R, Ajjarapu A, Karam L, Vogel AM, Rodriguez JR, Kellermayer R. Progression to colectomy in the era of biologics: A singly center experience with pediatric ulcerative colitis. J Pediar Surg. 2020 Feb 3:S0022-3468(20)30097-X. doi: 10.1016/j.jpedsurg.2020.01.054. Online ahead of print.